Efficacy and Safety of Inhaled Iloprost in Japanese Patients With Pulmonary Arterial Hypertension　– Insights From the IBUKI and AIR Studies

Efficacy and Safety of Inhaled Iloprost in Japanese Patients With Pulmonary Arterial Hypertension　– Insights From the IBUKI and AIR Studies –

Published:2016 Issue:4 Volume:80 Page:835-842
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Saji Tsutomu¹,Myoishi Masafumi²,Sugimura Koichiro³,Tahara Nobuhiro⁴,Takeda Yutaka⁵,Fukuda Keiichi⁶,Olschewski Horst⁷,Matsuda Yoshimi²,Nikkho Sylvia⁸,Satoh Toru⁹

Affiliation:

1. Department of Pediatrics, Toho University Omori Medical Center

2. Bayer Yakuhin Ltd

3. Tohoku University Graduate School of Medicine

4. Kurume University

5. Nagoya City University

6. Keio University School of Medicine

7. Medical University of Graz

8. Bayer Pharma AG

9. Kyorin University Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/4/80_CJ-16-0097/_pdf

Reference18 articles.

1. 1. Dai Z, Sugimura K, Fukumoto Y, Tatebe S, Miura Y, Nochioka K, et al. Visualization of complete regression of pulmonary arterial remodeling on optical coherence tomography in a patient with pulmonary arterial hypertension. Circ J 2014; 78: 2771–2773.

2. 2. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46: 903–975.

3. 3. Matsubara H, Ogawa A. Treatment of idiopathic/hereditary pulmonary arterial hypertension. J Cardiol 2014; 64: 243–249.

4. 4. Montani D, Gunther S, Dorfmuller P, Perros F, Girerd B, Garcia G, et al. Pulmonary arterial hypertension. Orphanet J Rare Dis 2013; 8: 97.

5. 5. Nergui S, Fukumoto Y, Do.e Z, Nakajima S, Shimizu T, Ikeda S, et al. Role of endothelial nitric oxide synthase and collagen metabolism in right ventricular remodeling due to pulmonary hypertension. Circ J 2014; 78: 1465–1474.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of iloprost in the treatment of pulmonary arterial hypertension: A systematic review and meta-analysis;Heart & Lung;2024-03

2. Pulmonary hypertension inhaled therapies: An updated review;The American Journal of the Medical Sciences;2023-07

3. Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension;Pulmonary Circulation;2023-01

4. Inhaled iloprost induces long‐term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy;Pulmonary Circulation;2022-04

5. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP);Journal of Medical Internet Research;2021-10-08